Aromatase immunoreactivity is increased in mammographically dense regions of the breast

Breast Cancer Research and Treatment

Volumn 125, Issue 1, 2011, Pages 243-252

  Vachon, Celine M ^a   Sasano, Hironobu ^b   Ghosh, Karthik ^a   Brandt, Kathleen R ^a   Watson, David A ^a   Reynolds, Carol ^a   Lingle, Wilma L ^a   Goss, Paul E ^c   Li, Rong ^e   Aiyar, Sarah E ^d   Scott, Christopher G ^a   Pankratz, V Shane ^a   Santen, Richard J ^d   Ingle, James N ^a  

^a MAYO CLINIC   (United States)

^b TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^e UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Aromatase; Breast density; Dense area

Indexed keywords

AROMATASE; BIOTIN; ESTROGEN; STREPTAVIDIN;

ADIPOCYTE; ADULT; AGED; ARTICLE; BREAST BIOPSY; BREAST CANCER; BREAST EPITHELIUM; CELL TYPE; CONTROLLED STUDY; ECHOMAMMOGRAPHY; ESTROGEN SYNTHESIS; FEMALE; GENE AMPLIFICATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MAMMOGRAPHIC BREAST DENSITY; MAMMOGRAPHY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIOLOGICAL PARAMETERS; STROMA;

ADIPOCYTES; ADULT; AGED; AGED, 80 AND OVER; AROMATASE; BIOPSY; BREAST; BREAST NEOPLASMS; EPITHELIAL CELLS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MAMMOGRAPHY; MIDDLE AGED; RISK ASSESSMENT; RISK FACTORS; STROMAL CELLS; UP-REGULATION;

EID: 78651096592     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-010-0944-6     Document Type: Article

References (38)

1. VA McCormack R Highnam N Perry I dos Santos Silva 2007 Comparison of a new and existing method of mammographic density measurement: intramethod reliability and associations with known risk factors Cancer Epidemiol Biomarkers Prev 16 1148 1154 10.1158/1055-9965.EPI-07-0085 17548677 (Pubitemid 46984951)
2. LJ Martin NF Boyd 2008 Mammographic density. Potential mechanisms of breast cancer risk associated with mammographic density: hypotheses based on epidemiological evidence Breast Cancer Res 10 201 10.1186/bcr1831 18226174
3. GA Greendale SL Palla G Ursin GA Laughlin C Crandall MC Pike BA Reboussin 2005 The association of endogenous sex steroids and sex steroid binding proteins with mammographic density: results from the Postmenopausal Estrogen/Progestin Interventions Mammographic Density Study Am J Epidemiol 162 826 834 10.1093/aje/kwi286 16177147 (Pubitemid 41541366)
4. M Verheus PH Peeters PA van Noord YT van der Schouw DE Grobbee CH van Gils 2007 No relationship between circulating levels of sex steroids and mammographic breast density: the Prospect-EPIC cohort Breast Cancer Res 9 R53 10.1186/bcr1758 17692133 (Pubitemid 350187470)
5. VA McCormack M Dowsett E Folkerd N Johnson C Palles B Coupland JM Holly SJ Vinnicombe NM Perry I dos Santos Silva 2009 Sex steroids, growth factors and mammographic density: a cross-sectional study of UK postmenopausal Caucasian and Afro-Caribbean women Breast Cancer Res 11 R38 10.1186/bcr2325 19545414
6. RM Tamimi C Byrne GA Colditz SE Hankinson 2007 Endogenous hormone levels, mammographic density, and subsequent risk of breast cancer in postmenopausal women J Natl Cancer Inst 99 1178 1187 1:CAS:528:DC%2BD2sXpt1aktr8%3D 10.1093/jnci/djm062 17652278 (Pubitemid 47233068)
7. WR Miller J O'Neill 1987 The importance of local synthesis of estrogen within the breast Steroids 50 537 548 1:STN:280:DyaL1M%2Fntlaitw%3D%3D 10.1016/0039-128X(87)90037-7 3504615
8. AK Dunbier H Anderson E Folkerd Z Ghazoui IE Smith MJ Ellis M Dowsett Neoadjuvant Letrozole Study Group 2009 Expression of estrogen responsive genes in breast cancers correlates with plasma estradiol levels in postmenopausal women Cancer Res 69 63
9. WR Miller JM Dixon L Macfarlane D Cameron TJ Anderson 2003 Pathological features of breast cancer response following neoadjuvant treatment with either letrozole or tamoxifen Eur J Cancer 39 462 468 1:CAS:528:DC%2BD3sXhtVemurY%3D 10.1016/S0959-8049(02)00600-7 12751376 (Pubitemid 36173690)
10. W Yue JP Wang CJ Hamilton LM Demers RJ Santen 1998 In situ aromatization enhances breast tumor estradiol levels and cellular proliferation Cancer Res 58 927 932 1:CAS:528:DyaK1cXhsFersrk%3D 9500452
11. A Lipton HA Harvey LM Demers JR Hanagan MT Mulagha GM Kochak S Fitzsimmons SI Sanders RJ Santen 1990 A phase I trial of CGS 16949A. A new aromatase inhibitor Cancer 65 1279 1285 1:STN:280:DyaK3c7mslGrtw%3D%3D 10.1002/1097-0142(19900315)65:6<1279::AID-CNCR2820650604>3.0.CO;2-3 2137721
12. A Brodie Q Lu B Long 1999 Aromatase and its inhibitors J Steroid Biochem Mol Biol 69 205 210 1:CAS:528:DyaK1MXktlOmtLY%3D 10.1016/S0960-0760(99)00051-5 10418994 (Pubitemid 29305538)
13. L Morales P Neven R Paridaens 2005 Choosing between an aromatase inhibitor and tamoxifen in the adjuvant setting Curr Opin Oncol 17 559 565 1:CAS:528:DC%2BD2MXhtFSis7%2FO 10.1097/01.cco.0000180434.31991.bf 16224233 (Pubitemid 41566408)
14. RJ Santen J Martel M Hoagland F Naftolin L Roa N Harada L Hafer R Zaino SJ Santner 1994 Stromal spindle cells contain aromatase in human breast tumors J Clin Endocrinol Metab 79 627 632 1:STN:280:DyaK2czitFCqsA%3D%3D 10.1210/jc.79.2.627 8045987 (Pubitemid 24256565)
15. NF Boyd LJ Martin MJ Yaffe S Minkin 2006 Mammographic density: a hormonally responsive risk factor for breast cancer J Br Menopause Soc 12 186 193 10.1258/136218006779160436 17178021 (Pubitemid 46017608)
16. S Alowami S Troup S Al-Haddad I Kirkpatrick PH Watson 2003 Mammographic density is related to stroma and stromal proteoglycan expression Breast Cancer Res 5 R129 R135 1:CAS:528:DC%2BD3sXntFaksb4%3D 10.1186/bcr622 12927043
17. T Li L Sun N Miller T Nicklee J Woo L Hulse-Smith MS Tsao R Khokha L Martin N Boyd 2005 The association of measured breast tissue characteristics with mammographic density and other risk factors for breast cancer Cancer Epidemiol Biomarkers Prev 14 343 349 10.1158/1055-9965.EPI-04-0490 15734956 (Pubitemid 40270095)
18. D Hawes S Downey CL Pearce S Bartow P Wan MC Pike AH Wu 2006 Dense breast stromal tissue shows greatly increased concentration of breast epithelium but no increase in its proliferative activity Breast Cancer Res 8 R24 10.1186/bcr1408 16646977 (Pubitemid 44377907)
19. PC Stomper RB Penetrante SB Edge MA Arredondo LE Blumenson CC Stewart 1996 Cellular proliferative activity of mammographic normal dense and fatty tissue determined by DNA S phase percentage Breast Cancer Res Treat 37 229 236 1:STN:280:DyaK28vit1GitQ%3D%3D 10.1007/BF01806504 8825134 (Pubitemid 26030100)
20. QJ Khan BF Kimler AP O'Dea CM Zalles P Sharma CJ Fabian 2007 Mammographic density does not correlate with Ki-67 expression or cytomorphology in benign breast cells obtained by random periareolar fine needle aspiration from women at high risk for breast cancer Breast Cancer Res 9 R35 10.1186/bcr1683 17537236 (Pubitemid 350215172)
21. M Verheus G Maskarinec E Erber JS Steude J Killeen BY Hernandez JM Cline 2009 Mammographic density and epithelial histopathologic markers BMC Cancer 9 182 10.1186/1471-2407-9-182 19523235
22. JA Harvey RJ Santen GR Petroni VE Bovbjerg ME Smolkin FS Sheriff J Russo 2008 Histologic changes in the breast with menopausal hormone therapy use: correlation with breast density, estrogen receptor, progesterone receptor, and proliferation indices Menopause 15 67 73 17558338
23. SJ Santner RJ Pauley L Tait J Kaseta RJ Santen 1997 Aromatase activity and expression in breast cancer and benign breast tissue stromal cells J Clin Endocrinol Metab 82 200 208 1:CAS:528:DyaK2sXkt1egsA%3D%3D 10.1210/jc.82.1.200 8989259 (Pubitemid 27021297)
24. S Ghosh A Choudary S Ghosh N Musi Y Hu R Li 2009 IKKbeta mediates cell shape-induced aromatase expression and estrogen biosynthesis in adipose stromal cells Mol Endocrinol 23 662 670 1:CAS:528:DC%2BD1MXlsFCgtr0%3D 10.1210/me.2008-0468 19221050
25. SE Bulun Z Lin G Imir S Amin M Demura B Yilmaz R Martin H Utsunomiya S Thung B Gurates, et al. 2005 Regulation of aromatase expression in estrogen-responsive breast and uterine disease: from bench to treatment Pharmacol Rev 57 359 383 1:CAS:528:DC%2BD2MXhtVersLjI 10.1124/pr.57.3.6 16109840 (Pubitemid 41196955)
26. J Zhou B Gurates S Yang S Sebastian SE Bulun 2001 Malignant breast epithelial cells stimulate aromatase expression via promoter II in human adipose fibroblasts: an epithelial-stromal interaction in breast tumors mediated by CCAAT/enhancer binding protein beta Cancer Res 61 2328 2334 1:CAS:528: DC%2BD3MXit1OgtL8%3D 11280806
27. SE Bulun TM Price J Aitken MS Mahendroo ER Simpson 1993 A link between breast cancer and local estrogen biosynthesis suggested by quantification of breast adipose tissue aromatase cytochrome P450 transcripts using competitive polymerase chain reaction after reverse transcription J Clin Endocrinol Metab 77 1622 1628 1:CAS:528:DyaK2cXhtVenu7c%3D 10.1210/jc.77.6.1622 8117355 (Pubitemid 24000924)
28. SE Bulun ER Simpson 1994 Regulation of aromatase expression in human tissues Breast Cancer Res Treat 30 19 29 1:CAS:528:DyaK2cXmt1ais7w%3D 10.1007/BF00682738 7949202 (Pubitemid 24250756)
29. SE Bulun G Sharda J Rink S Sharma ER Simpson 1996 Distribution of aromatase P450 transcripts and adipose fibroblasts in the human breast J Clin Endocrinol Metab 81 1273 1277 1:CAS:528:DyaK28Xhs1agtL0%3D 10.1210/jc.81.3.1273 8772611 (Pubitemid 26084463)
30. GJ Liu YS Wu D Brenin W Yue S Aiyar A Gompel JP Wang RR Tekmal RJ Santen 2008 Development of a high sensitivity, nested Q-PCR assay for mouse and human aromatase Breast Cancer Res Treat 111 343 351 1:CAS:528:DC%2BD1cXptVCntLs%3D 10.1007/s10549-007-9792-4 17975728
31. SJ Santner PD Feil RJ Santen 1984 In situ estrogen production via the estrone sulfatase pathway in breast tumors: relative importance versus the aromatase pathway J Clin Endocrinol Metab 59 29 33 1:CAS:528:DyaL2cXks1Khtrk%3D 10.1210/jcem-59-1-29 6725522
32. T Suzuki T Nakata Y Miki C Kaneko T Moriya T Ishida S Akinaga H Hirakawa M Kimura H Sasano 2003 Estrogen sulfotransferase and steroid sulfatase in human breast carcinoma Cancer Res 63 2762 2770 1:CAS:528:DC%2BD3sXkt1aju7Y%3D 12782580 (Pubitemid 36667146)
33. Y Miki T Nakata T Suzuki AD Darnel T Moriya C Kaneko K Hidaka Y Shiotsu H Kusaka H Sasano 2002 Systemic distribution of steroid sulfatase and estrogen sulfotransferase in human adult and fetal tissues J Clin Endocrinol Metab 87 5760 5768 1:CAS:528:DC%2BD38XpslWmsr8%3D 10.1210/jc.2002-020670 12466383 (Pubitemid 36034387)
34. CM Vachon JN Ingle VJ Suman CG Scott H Gottardt JE Olson PE Goss 2007 Pilot study of the impact of letrozole vs. placebo on breast density in women completing 5 years of tamoxifen Breast 16 204 210 1:STN:280: DC%2BD2s7pvFSgtg%3D%3D 10.1016/j.breast.2006.10.007 17145182 (Pubitemid 46499237)
35. J Cuzick J Warwick E Pinney RM Warren SW Duffy 2004 Tamoxifen and breast density in women at increased risk of breast cancer J Natl Cancer Inst 96 621 628 1:CAS:528:DC%2BD2cXjsVektb4%3D 10.1093/jnci/djh106 15100340
36. Cigler T, Tu D, Yaffe MJ, Findlay B, Verma S, Johnston D, Richardson H, Hu H, Qi S, Goss PE (2009) A randomized, placebo-controlled trial (NCIC CTG MAP1) examining the effects of letrozole on mammographic breast density and other end organs in postmenopausal women. Breast Cancer Res Treat. 2009 Dec 6 [Epub ahead of print]
37. CJ Fabian BF Kimler CM Zalles QJ Khan MS Mayo TA Phillips M Simonsen T Metheny BK Petroff 2007 Reduction in proliferation with six months of letrozole in women on hormone replacement therapy Breast Cancer Res Treat 106 75 84 1:CAS:528:DC%2BD2sXhtFSmu7rP 10.1007/s10549-006-9476-5 17221152 (Pubitemid 47498093)
38. NA Mousa P Crystal WL Wolfman MA Bedaiwy RF Casper 2008 Aromatase inhibitors and mammographic breast density in postmenopausal women receiving hormone therapy Menopause 15 875 884 10.1097/gme.0b013e31816956c3 18480735